Two Bio Sante execs call for an FDA-approved hypoactive sexual desire disorder treatment
A paper set to appear in next month’s issue of The Journal of Sexual Medicine by two executives from BioSante Pharmaceuticals calls for a Food and Drug Administration-approved testosterone treatment for hypoactive sexual desire disorder.
The paper, “Approved Hormonal Treatment for HSDD: An Unmet Medical Need,” by BioSante president and CEO Stephen Simes and VP clinical development Michael Snabes uses results from independent surveys indicating that 80% of physicians see a need or great need for an FDA-approved treatment for women with HSDD, and 90% of them would prescribe an approved product rather than currently available off-label therapies.
The high number of off-label prescriptions is related to an increase in the number of women with HSDD seeking treatment for distress resulting from their decrease in sexual desire, and Simes and Snabes wrote that low sexual desire is “nearly twice as high in naturally menopausal women as in pre-menopausal women (52.4% vs. 26.7%).”
BioSante is conducting two phase 3 efficacy studies and one phase 3 safety study of LibiGel (testosterone gel) and plans to submit an approval application to the FDA by mid-2011.
NBGH recognizes employers that promote healthy living
WASHINGTON A nonprofit organization has awarded more than 60 employers for promoting healthy living.
The National Business Group on Health announced Wednesday that it had recognized 63 large employers as the winners of the “2009 Best Employers for Healthy Lifestyles” award.
“We are proud to recognize 63 large employers for their unparalleled commitment to a healthy workplace and for making their employees’ health and well-being a top priority,” NGBH president Helen Darling said. “Employers know first-hand that a healthy workforce is essential to increasing productivity and to maintaining a competitive edge in the new global economy.”
Companies that won the award – given in Platinum, Gold and Silver categories – included Hannaford Supermarkets, Boehringer Ingelheim Pharmaceuticals, CVS Caremark, General Mills, Wal-Mart, Cardinal Health, Meijer and Target.
MinuteClinic becomes participating provider in all CareFirst Blue Cross Blue Shield plans
MINNEAPOLIS MinuteClinic is now a participating provider in insurance plans offered by CareFirst Blue Cross Blue Shield in Maryland, Virginia and Washington, D.C., the company announced on Wednesday.
Nearly 3.4 million CareFirst members now have in-network access to MinuteClinic healthcare centers located inside select CVS/pharmacy stores in Maryland and portions of northern Virginia in the CareFirst service area.
Previously, MinuteClinic was a participating provider with CareFirst’s preferred provider and federal employee plans in Maryland only.
“This is an important development in the growth of our business in Maryland and northern Virginia as we expand access to care to new customers,” stated Chip Phillips, MinuteClinic president. “By offering high-quality treatment in a convenient setting, we are working with CareFirst to help reduce healthcare insurance expenses for its members, as well as time spent away from members’ families and the workplace.”
MinuteClinic, which is owned by CVS Caremark, has about 500 locations in 25 states.